News
- Crescendo Bioscience® Receives Accreditation from the College of American Pathologists
- Crescendo Bioscience® Announces Laboratory Clearance For Use of Vectra® DA in New York State
- Crescendo Bioscience® Announces Global Launch of Innovative iPhone App To Help Track Rheumatoid Arthritis
- Crescendo Bioscience® Secures $28 Million in Series D Financing
- Crescendo Bioscience To Present Data on the Use of Vectra™ DA in Assessing Response to Treatments at American College of Rheumatology/Associate Rheumatology Health Professional Annual Meeting
- Ron Leuty, Reporter San Francisco Business Times, Discusses Crescendo Bioscience’s Rheumatoid Arthritis Test
- Study Validates Use of Crescendo Bioscience’s Vectra DA Test As An Objective Measure of Rheumatoid Arthritis Disease Activity
- Crescendo Bioscience® Names Industry Leader Oscar Segurado, M.D., Ph.D., Chief Medical Officer
- Crescendo Bioscience’s Vectra™ DA Test Indicates Remission in Rheumatoid Arthritis Patients
- John Russell, executive editor of Bio-IT World, profiles Crescendo Bioscience’s use of biomarkers in the rise of personalized medicine.
- Studies Show Vectra™ DA Multi-Biomarker Test Algorithm More Accurate Than Other Established Disease Activity Measures In Identifying Rheumatoid Arthritis Patients At Risk For Joint Damage Progression
- Crescendo Bioscience Secures $56 Million in Funding to Expand Development and Commercialization of Personalized Diagnostics for Inflammatory Diseases
- Studies Show Crescendo Bioscience’s Vectra™ DA Can Track Early Response to Rheumatoid Arthritis Therapy and Predict Joint Damage at the Molecular Level
- Updates from the European League Against Rheumatism (EULAR) Congress 2011
- Rheumatology-congress.co.uk website highlights Vectra DA validation data from the 2010 American College of Rheumatology (ACR) Annual Scientific Meeting
- Crescendo Bioscience™, Inc. announces the U.S. launch of the first multi-biomarker blood test for rheumatoid arthritis disease activity
- Updates from the American College of Rheumatology (ACR) 2010 Annual Scientific Meeting
- Consortium Announces Study to Investigate Predictive Biomarkers in Patients with Rheumatoid Arthritis Receiving TNF Inhibitors
- Listen to Dr. Moira Gunn and Dr. David Chernoff discuss rheumatoid arthritis and Vectra™ DA
- The Institute for Continuing Healthcare Education: Focus on Personalized Medicine